Digoxin Inj.Sol. 0.25mg/ml (2ml Amp) (EU CTD Available)

Digoxin Inj.Sol. 0.25mg/ml (2ml Amp) (EU CTD Available)
Product Description

Digoxin 0.25mg/ml Solution for Injection (2ml Amp)
Reference Product: Lanoxin® / GSK
Description: Digoxin is indicated in the management of chronic cardiac failure especially where cardiac failure is accompanied by atrial fibrillation, Supraventricular arrhythmias particularly chronic atrial fibrillation and flutter, where its major beneficial effect is to reduce the ventricular rate and when emergency parenteral digitilisation is required in patients who have not been given cardiac glycosides within the preceding two weeks. 
Dossier Status: EU CTD Available
Stability Studies: Zone II / Zone IVb
Shelf life: Three (3) years
Batch Sizes: 40,000 Ampoules
Pack Sizes: BT x 6 Ampoules

Read more Show less

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Greece
More specifications Fewer specifications
Sales Markets
Show more Show less

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since
View company profile

More Products from ANFARM HELLAS S.A. (36)

  • Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development)

    Product Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development)

    Ceftaroline Fosamil Powder for Concentrate for Solution for Infusion 600mg/vial
    Reference Product: Zinforo® / Pfizer
    Description: For the treatment of the following infections in neonates, infants, children, adolescents and adults, Complicated skin and soft tissue infections (cSSTI),&...
  • Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available)

    Product Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available)

    Ceftriaxone 1g/Vial Powder for Solution for Injection/Infusion 
    Reference Product: Farcef®  / Angelini
    Description: Ceftriaxone is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible isolates of the desig...
  • Cefuroxime Pd.Inj.Sol 750mg/Vial & 1.5g/Vial (EU CTD Available)

    Product Cefuroxime Pd.Inj.Sol 750mg/Vial & 1.5g/Vial (EU CTD Available)

    Cefuroxime 750mg /Vial & 1.5g/Vial Powder for Solution for Injection 
    Reference Product: Zinadol® / GSK
    Description: Cefuroxime is an antibiotic used to treat certain infections caused by bacteria, including respiratory-tract infections such as tonsillitis and pharyngitis (infections...
  • Clarithromycin Pd.Sol.Inf. 500mg/Vial (EU CTD Available)

    Product Clarithromycin Pd.Sol.Inf. 500mg/Vial (EU CTD Available)

    Clarithromycin 500mg/Vial Powder for Solution for Infusion Reference Product: Klaricid® / ABBOTT
    Description: Clarithromycin has a longer serum half-life and better tissue penetration than erythromycin, allowing twice-a-day dosing for most common infections.  Clarithromycin as a powder for sol...
  • Clindamycin Solution for Injection 150mg/ml (EU CTD Available: 2022)

    Product Clindamycin Solution for Injection 150mg/ml (EU CTD Available: 2022)

    Clindamycin 150mg/ml Solution for Injection (2ml & 4ml amps)  Dalacin® / PfizerDescription: Antibacterial.  Serious infections caused by susceptible Gram-positive organisms, staphylococci (both penicillinase- and non-penicillinase-producing), streptococci (except Streptococcus faecalis) ...
  • Daptomycin Pd.I.S.Inf. 350 & 500mg/Vial (EU CTD Available)

    Product Daptomycin Pd.I.S.Inf. 350 & 500mg/Vial (EU CTD Available)

    Daptomycin 350 & 500mg/Vial Powder for Solution for Injection or Infusion
    Reference Product: Cubicin® / MSD Description:Daptomycin is an antibacterial (cyclic lipopeptide natural product) that is active against Gram positive bacteria and is indicated for the treatment of the following infe...
  • Esomeprazole Pd.I.S.Inf 40mg/Vial (EU CTD Available)

    Product Esomeprazole Pd.I.S.Inf 40mg/Vial (EU CTD Available)

    Esomeprazole 40 mg/Vial Powder for Solution for Injection/Infusion
    Reference Product: Nexium® / Pfizer
    Description: Esomeprazole is a proton pump inhibitor indicated for the treatment of the Gastroesophageal Reflux Disease (GERD) with erosive esophagitis (EE) in adults and pediatric patients...
  • Ertapenem Pd.C.So.In 1g/Vial (under development)

    Product Ertapenem Pd.C.So.In 1g/Vial (under development)

    Ertapenem 1gPowder for concentrate for solution for infusion
    Reference Product: Invanz® / MSD
    Description: Ertapenem is a Carbapenem Antibiotic indicated in paediatric patients and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible t...
  • Imipenem + Cilastatin Pd.Sol.Inf (500+500)mg/Vial (EU CTD Available)

    Product Imipenem + Cilastatin Pd.Sol.Inf (500+500)mg/Vial (EU CTD Available)

    Imipenem + Cilastatin (500+500) mg/Vial Powder for Solution for Infusion
    Reference Product: Primaxin® / Merck
    Description:  Imipenem + Cilastatin is a combination of imipenem, a penem antibacterial, and cilastatin, a renal dehydropeptidase inhibitor, indicated for the treatment of ...
  • Isavuconazole Pd.C.So.In 200mg/Vial (under development)

    Product Isavuconazole Pd.C.So.In 200mg/Vial (under development)

    Isavuconazole 200mg Powder for concentrate for solution for infusion
    Reference Product: Cresemba® / Basilea Pharmaceutica (Pfizer)
    Description: Isavuconazole is an antifungal agent which is indicated in adults for the treatment of:
    • invasive aspergillosis
    • mucormycosis in patients for whom am...
  • Lacosamide Oral Solution 10mg/ml (EU CTD Available: Q2 2022)

    Product Lacosamide Oral Solution 10mg/ml (EU CTD Available: Q2 2022)

    Lacosamide 10mg/ml Oral Solution
    Reference Product: Vimpat® / UCB Description: Lacosamide is a functionalised amino acid which belongs to the group of antiepileptics. Lacosamide is used as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary...
  • Lacosamide Solution for Infusion 10mg/ml (EU CTD Available: Q2 2021)

    Product Lacosamide Solution for Infusion 10mg/ml (EU CTD Available: Q2 2021)

    Lacosamide 10mg/ml Solution for Infusion
    Reference Product: Vimpat® / UCB Description: Lacosamide is a functionalised amino acid which belongs to the group of antiepileptics. In vitro electrophysiological studies have shown that lacosamide selectively enhances slow inactivation of voltage-gated s...
show all 36 other products

ANFARM HELLAS S.A. resources (2)